• Welcome
• Committees
• Meet the Speakers
• General Information
• Final Program
• Invited Presentations
• Company Presentation
• One on One Meetings
• Registration Information
• Accommodation
• Highlights and Topics
• Invitation Letter
• Sponsors

• ACRP Conference

• Biotech 2005
• Biotech 2004

CONFERENCE HIGHLIGHTS AND TOPICS

Following last year’s success the Organizing Committee continues to highlight specific disease states and certain basic issues common to our industry.
The Organizing Committee has decided to integrate into the conference the successful and vibrant Israeli medical device sector and as such we are committed to making the BIOMED 2006 conference a showcase of the entire Israeli life sciences industry.

We are pleased to note that this year the Israeli Cardiovascular association and the Israeli Association of Bioengineering joined Biomed as sponsors of their respective sessions.

This year the conference will be dedicated to four therapeutic areas in which Israel has much to offer:

• Cardiovascular diseases-Cardiology is a major disease area with significant unmet needs, Israel is a fertile source of innovation in this area in both innovative therapies and breakthrough medical devices
• Orthopedics has the perception of a mature area. Renowned Keynote presenters from academia and industry will discuss breakthrough scientific and technological advances in this field.
• Nerve Stimulation is being recognized as a new way to intervene in the actuation / deactivation of muscle and glands involved in many disease states. Worldwide pioneers in this field will present their work and vision for this new exciting area.
• Biomarkers/Imaging- The future of our industry will be highly dependent on our ability to develop and validate biomarkers as diagnostics, research tools and surrogate study end points.We are pleased to announce that world-renowned experts Dr. Marvin Woodall, Dr. Mitchell Krucoff, Prof. Arnold Caplan and Prof. Kim Burchiel will be keynote speakers in these sessions.

The conference will conclude with a special half day session dedicated to:

• Healthcare beyond 2010- The healthcare environment is nearing an inflection point. Rising costs, diminishing innovation and changing regulatory environment are bound to drive significant changes to our industry.

Esteemed speakers such as Steven Burrill, CEO Burrill & Co, Tamar Howson, VP Bristol Myers-Squibb and Dr. George Poste, Director of Biodesign Institute will present their views on what the future will look like.